Search for: "Tom Lamb"
Results 501 - 520
of 1,045
Sorted by Relevance
|
Sort by Date
19 Oct 2015, 10:25 am
(Case review done by attorney Tom Lamb) [read post]
12 Dec 2014, 9:29 am
We will continue to monitor this Bayer birth control pills litigation and periodically report developments here, as we have over the past few several years. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Case review done by attorney Tom Lamb) [read post]
9 Apr 2020, 11:52 am
(Case review is done by attorney Tom Lamb) [read post]
15 Jan 2013, 2:09 pm
[Footnote omitted] In fact, here, we have heard from women who used Actonel, Boniva, and Fosamax (alone or is some sequential combination) for five years, at least, that have been diagnosed with single leg or bilateral low-stress atypical femur fractures -- albeit this is not the basis for a medical or scientific determination as regards this controversial and still developing drug-safety issue. ______________________________________________________________________________… [read post]
9 Mar 2015, 1:46 pm
We will watch for further developments surrounding the safety profile of Onglyza and Kombiglyze XR as well as these other incretin mimetic diabetes drugs. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Case review done by attorney Tom… [read post]
21 Feb 2018, 1:40 pm
(Case review done by attorney Tom Lamb) [read post]
27 Sep 2016, 1:55 pm
(Case review done by attorney Tom Lamb) [read post]
22 May 2018, 12:20 pm
(Case review done by attorney Tom Lamb) [read post]
4 Nov 2019, 2:15 pm
(Case review is done by attorney Tom Lamb) [read post]
2 Jul 2015, 12:33 pm
(Case review done by attorney Tom Lamb) [read post]
15 Aug 2022, 12:35 pm
We encourage you to submit an online Camp Lejeune Case Evaluation Form to tell us the basic facts of the possible Camp Lejeune cancer case or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb. [read post]
4 May 2007, 2:56 pm
Drug Companies Also State There Have Been No Reports Of Other "Serious Opportunistic Infections" Related To Recent Use Of Tysabri (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 3, 2007 Wall Street Journal (WSJ) article, Jennifer Corbett Dooren gave us an update of the safety profile of the multiple-sclerosis drug Tysabri:There have been no additional reports of a serious brain infection known as progressive multifocal leukoencephalopathy, or PML, among… [read post]
9 Oct 2009, 12:27 pm
Prompted By Investigation Into Death Of Young Woman Who Died While Using Yaz; Results Of Analysis Expected In Late October 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) In late September 2009 we learned that the Swiss drug safety oversight regulator, Swissmedic, was investigating a possible link between the use of Yaz and a fatal pulmonary embolism (PE) suffered by a young woman in Switzerland earlier that month. [read post]
11 Apr 2007, 6:59 am
Judge Victoria Chaney To Consider Status Of Upcoming California State Court Vioxx Trials At April 11, 2007 Hearing (Posted by Tom Lamb at DrugInjuryWatch.com) Plaintiff Lowell Berwick, who claimed his March 2004 heart attack at age 61 was caused by his ten-months use of Vioxx, dropped his lawsuit against Merck & Co. on April 9, 2007, the day before jury selection for his California state court trial was to start. [read post]
23 Jan 2007, 8:27 pm
(Posted by Tom Lamb at DrugInjuryWatch.com)The January 9, 2007 edition of the medical journal Neurology has a report concerning a new study which reveals that elderly patients using the blood-thinning medicine warfarin may be at greater risk for having a serious brain hemorrhage. [read post]
3 Apr 2007, 2:55 pm
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had suspended the marketing and sales of Zelnorm (tegaserod), a widely prescribed medication for irritable bowel syndrome (IBS) and constipation, due to an apparent increased risk of heart attacks and strokes in patients using Zelnorm. [read post]
19 Oct 2007, 5:14 am
Package Insert Will Be Changed To Include Stronger Warning About This Potentially Fatal Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) On October 16, 2007 the FDA issued an alert to doctors informing them that the agency had reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), a drug used to treat adults with type 2 diabetes. [read post]
8 Apr 2009, 12:38 pm
Information Current As Of December 31, 2008; FDA Says It Will Provide Quarterly Updates For This AERS Data (Posted by Tom Lamb at DrugInjuryWatch.com) In early April 2009 the FDA released its Adverse Event Reporting System (AERS) Statistics as of December 31, 2008. [read post]
23 Oct 2008, 4:25 pm
Get Background Information, Opinions, And Resources For This Important Legal And Public Policy Issue (Posted by Tom Lamb at DrugInjuryWatch.com) On November 3, 2008 the U.S. [read post]
17 Jun 2009, 10:39 am
Medtronic Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) On June 18, 2009 the Health Subcommittee of the House Energy and Commerce Committee will have a hearing on the Medical Device Safety Act of 2009 (H.R. 1346). [read post]
